Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.
Conclusion: Evidence does not support use of the studied pharmacologic treatments for cognitive protection in persons with normal cognition or MCI.
Primary Funding Source: Agency for Healthcare Research and Quality.
PMID: 29255847 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, Ratner E, Calvert C, Barclay TR, Brasure M, Nelson VA, Kane RL Tags: Ann Intern Med Source Type: research
More News: Alzheimer's | Aspirin | Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cholesterol | Coronary Heart Disease | Databases & Libraries | Dementia | Diabetes | Endocrinology | Evista | Heart | Heart Disease | Hormones | Internal Medicine | Pulmonary Thromboembolism | Statin Therapy | Stroke | Study | Thrombosis